Lpath Incorporated

• Home
• About Lpath
  • Brief Overview
  • Company Summary
  • Pipeline
  • Our Novel Approach
  • Patent Portfolio
  • Pioneers of the Category
• The Lpath Team
  • Executive Team
  • Board of Directors
  • Advisory Boards
    • Clinical
    • Ocular
    • Scientific
• The Science: An Overview
  • Technical Overview
    • S1P Target
    • LPA Target
  • Science of Cancer
  • Angiogenesis Tutorial
  • Publications/Presentations/ Grants
• Investor Center
  • Investor Overview
  • Stock Information
  • News Releases
  • Calendar of Events
  • SEC Filings
  • Investor FAQ
  • Request Information
  • Email Alerts
• Legal, Important Notices
• Contact Us

Product Pipeline

Lpath's Product Pipeline: How ImmuneY2 Provides Potential Platform Capability